We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Two New Tracers Improve Diagnosis of Cancer

News   Mar 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Two New Tracers Improve Diagnosis of Cancer

68Ga-FAPI-2 and 68Ga-FAPI-4 at 10 minutes, 1 hour, and 3 hours after injection. Rapid tumor targeting and fast blood clearance are followed by long plateau phase without relevant change in image contrast (top). In comparison to 68Ga-FAPI-2, 68Ga-FAPI-4 is characterized by prolonged tumor retention time (bottom). LW = lumbar body. Credit: Giesel FL, Kratochwil C, Lindner T, et al.

 
 
 

RELATED ARTICLES

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Long-hidden Metabolic System Unlocks Cancer Secrets

News

Researchers have identified a long-hidden metabolic system in cells, which could provide a new opportunity to find ways to suppress cell proliferation in cancer.

READ MORE

Imaging Approach Refines Breast Cancer Classification

News

An imaging approach developed at UZH enables the study of breast cancer tissue in greater detail. It uses 35 biomarkers to identify the different cell types in breast tumors and its surrounding area compared to the current standard of testing single markers. This increases the precision of tumor analysis and classification - and improves personalized diagnostics for breast cancer patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE